2,165
Participants
Start Date
November 30, 2012
Primary Completion Date
May 31, 2014
Study Completion Date
May 31, 2014
Saxagliptin
oral, 5 mg once a day (Q.D.)
Research Site, Baotou
Research Site, Beijing
Research Site, Benxi
Research Site, Changchun
Research Site, Chengdu
Research Site, Chongqing
Research Site, Dalian
Research Site, Dongguan
Research Site, Foshan
Research Site, Fuzhou
Research Site, Guangzhou
Research Site, Guiyang
Research Site, Haikou
Research Site, Hangzhou
Research Site, Hhht
Research Site, Hubei
Research Site, Jimo
Research Site, Jinan
Research Site, Kunming
Research Site, Linyi
Research Site, Nanjing
Research Site, Nantong
Research Site, Qingdao
Research Site, Shanghai
Research Site, Shantou
Research Site, Shenyang
Research Site, Shiyan
Research Site, Suzhou
Research Site, Taiyuan
Research Site, Tianjin
Research Site, Ürümqi
Research Site, Wenzhou
Research Site, Wuhan
Research Site, Wuxi
Research Site, Xi'an
Research Site, Zhanjiang
Research Site, Zhengzhou
Lead Sponsor
AstraZeneca
INDUSTRY